Skip to main content
Download PDF
Download ePub

The effects of seed from Linum usitatissimum cultivar with increased phenylpropanoid compounds and hydrolysable tannin in a high cholesterol-fed rabbit

Lipids in Health and Disease volume 17, Article number: 76 (2018) Cite this article

Abstract

Background

Dietary fat is considered one of the most important factors associated with blood lipid metabolism and plays a significant role in the cause and prevention of atherosclerosis that has been widely accepted as an inflammatory disease of the vascular system. The aim of the present study was to evaluate the effect of genetically modified flaxseed (W86) rich in phenylpropanoid compounds and hydrolysable tannin in high cholesterol-induced atherosclerosis rabbit models compared to parental cultivar Linola.

Methods

Twenty-Eight White New Zealand white rabbits aged 6 months were randomly divided into four groups, control group, high cholesterol group (10 g/kg), Linola flaxseed group (100 g/kg) and W86 flaxseed group (100 g/kg). The rabbits were fed a normal diet or a high cholesterol diet for 10 weeks. Levels of blood lipids, hematological values, total antioxidative status and superoxide dismutase activity in serum were determined. Moreover, body weight and feed intake were measured after sixth and tenth weeks. After each stage of the experiment atherogenic indexes (non-HDL-C/HDL-C, LDL-C/HDL-C, and atherogenic index of plasma) was calculated.

Results

The intake of a dyslipidaemic diet negatively influenced lipid profile in rabbits at the 10 weeks of feeding. W86 flaxseed significantly decreased total cholesterol, LDL-C, VLDL-C and TG serum levels in cholesterolemic rabbits compared with parental Linola after 10 weeks. Atherogenic indexes decreased over time with a significant difference between the diets and they were the best for W86 flaxseed. Similarly, the experimental addition of W86 significantly decreased atherogenic predictors such as heterophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and the mean platelet volume-to-lymphocyte ratio. In rabbits, W86 flaxseed increased the activity of superoxide dismutase and total antioxidative status compared to Linola.

Conclusions

Results of the presented study suggest that the addition of W86 flaxseed alleviate serum lipid changes in high cholesterolemic diet-administered rabbits. W86 flaxseed significantly reduced atherogenic indexes, as compared with the Linola and indicate that W86 flaxseed more effectively red CVD risk factors during hypercholesterolemia. Moreover, the presented result suggested that W86 flaxseed can be a part of a heart-healthy and antiatherogenic diet for the human.

Background

According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of death worldwide, which represents 30% of all global deaths [1]. Dyslipidemia, including higher serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) and lower high-density lipoprotein cholesterol (HDL-C), is a major risk factor for atherosclerosis. When atherosclerotic processes take hold in the arteries that supply blood to the heart, the condition becomes coronary artery disease (CAD). Moreover, inflammations and elevated platelet counts are associated with poor cardiovascular outcomes [2]. Dietary fat is considered one of the most important factors associated with blood lipid metabolism and plays a significant role in the cause and prevention of atherosclerosis [3]. In addition to hypercholesterolemia, hypertriglyceridemia may be another factor for diseases. Because cholesterol lowering is a major target for reducing CVD risk, dietary interventions to reduce TC and TG levels in individuals with borderline dyslipidemia and obesity without overall cardiovascular risk are becoming mandatory [3]. Large-scale clinical trials using statins have shown a significant reduction in cardiovascular events, mainly due to the lowering of plasma concentrations of LDL-C; however, the capacity of statins to prevent cardiovascular events are still limited to 30% to 40% of the patients treated even when intensive statin therapy is used [3, 4]. Nutraceuticals and functional food ingredients that are beneficial to vascular health may represent useful compounds that are able to reduce the overall cardiovascular risk induced by dyslipidaemia by acting parallel to statins or as an adjuvants [5].

Flax (Linum usitatissimum L.) is among the oldest plants with great significance in food production, healthcare, pharmaceutics, and industry as a source of fibre and oil. Moreover, flaxseed is one of the key sources of phytochemicals in the functional food area [6]. In addition to being one of the richest sources of ω-3 fatty acids and lignans, flaxseed is an excellent source of high-quality protein and soluble fibre and has considerable potential as a source of phenolic compounds [6]. It is established that polyunsaturated fatty acids (PUFA) like ω-3 (α-linolenic acid, ALA) and ω-6 (linoleic acid, LA) play important roles in human health and disease. Both are considered essential because they are not endogenously synthesized and must be obtained from the diet [7].

Due to the opposing effects of ω-3 and ω-6 fatty acids, a healthy diet should contain a balanced ω-6: ω-3 ratio. A balanced ω-6/ω-3 ratio 1–2/1 is one of the most important dietary. Human beings evolved eating a diet with a ω-6:ω-3 ratio of about 1:1 but modern diets exhibit LA: ALA ratios ranging between 15:1 to 30:1 [8, 9].

Excessive amounts of ω-6 and a very high ω-6/ω-3 ratio, promote the pathogenesis of many diseases, including cardiovascular disease, cancer, and inflammatory and autoimmune diseases, whereas increased level of ω-3 (a low ω-6/ω-3 ratio) exert suppressive effects [8, 10, 11]. L. usitatissimum cv. Linola seed exhibits an extremely high ω-6 to a ω-3 ratio (~ 31:1), so its health beneficial effect is rather limited [12]. However, new genetically modified L. usitatissimum L. namely W86 show the ~ 30-fold increase in α-linolenic acid level compared to the Linola cultivar [12]. Thus, the ratio of ω-6 to ω-3 in seed from W86 is about 1.3:1 [12], which is quite close to that recommended for the human diet [9]. Obviously, the bioavailability of ALA is dependent on the type of flax ingested [13].

Although, there are no data that suggest the LDL-C increases associated with some ω-3 fatty acid formulations lead to adverse outcomes, these increases in LDL-C may compromise the achievement of lipid targets; thus, there is a need for agents that can lower TG levels without increasing LDL-C levels [7] especially in individuals with high cholesterol levels.

Perhaps most importantly, there are some human conditions that cannot be adequately modelled by invertebrate or rodent species we chose rabbits. These animals are phylogenetically closer to primates than rodents and further offer a more diverse genetic background than inbred and outbred rodent strains [14]. The special characteristics of rabbit anatomy and physiology make it uniquely suitable for the study of hypercholesterolemia and atherosclerosis through diet which makes the model a better overall approximation to humans [15]. The rabbit model is highly reproducible with minimal variation between animals in a single laboratory and between laboratories.

Therefore, the purpose of presenting research was to identify the effect of flaxseed, a bioactive food compound on rabbits with high TC and TG levels. Particularly, this study aims to verify the clinical outcome of the change in the lipid profile due to the use of seeds from W86, a genetically modified Linum usitatissimum cv. Linola.

Moreover, the second objective was to determine if use of flax seeds with increase in α-linolenic acid level, and increased phenylpropanoid compounds, and hydrolysable tannin [12] has deleterious effects of red blood cells (RBCs), white blood cells (WBCs) and platelets and if these effects are different in normal and hypercholesterolemic rabbits.

Methods

Plant material

Flaxseed (cv. Linola) was obtained from the Flax and Hemp Collection of the Institute of Natural Fibres, Poland. Flaxseed W86 has been created with the aid of genetic engineering by agrotransformation of the Linola cultivar. In W86, down-regulation of the endogenous chalcone synthase gene (CHS) was achieved by overexpression of cDNA of the petunia homolog (CHS, EMBL/GenBank database acc. no. X04080) The details of plant transformation, selection, and transgenic plant analysis were described previously [12]. As a result of such overexpression, W86 plant demonstrates an increased phenylpropanoid contents resulting in a higher antioxidant capacity and accumulation of phenylpropanoid compounds as well as shows increase of hydrolysable tannin accumulation and reduction in lignin synthesis (Additional file 1: Table S1) [16]. Flaxseeds from control and transgenic plants were grown on a semi-technical scale in a field (Malbork, Poland) and harvested after 3 months of growth.

Animals, diets and experimental protocol

Twenty-Eight White Giant rabbits aged 6 months ranging in weight from 3800 to 4400 g were used for the study. Housing requirements can be readily met for rabbits [17, 18]. After the adaptation period (rabbits were all fed on a normal diet), the rabbits were randomly divided into four groups of seven animals each. The groups were designated CTRL, CHOL, LIN, and W86. Group CTRL consisted of the control animals, which were fed a basal mixture for rabbits composed of dried grass, dried alfalfa, wheat bran, wheat grain, barley grain, corn, soybean meal, rape meal, rapeseed oil and vitamin/mineral premix (Granum Animal Nutrition, Poland). The chemical analyses of basal feed used in the experimental diets are presented in Additional file 1: Table S2. Group CHOL received the same basal diet with 1% cholesterol. Group LIN received the same diet as group CHOL supplemented with 100 g/kg of Linola flaxseed. Group W86 received the same diet as group CHOL but additionally supplemented with 100 g/kg of W86 flaxseed. The dose of flaxseed was calculated on the basis of flaxseed used in other studies [17]. The diets and fresh water were provided ad libitum and all manipulations were carried out between 09:00 and 16:00.

Blood sampling

Blood samples were collected for analysis twice, after 6 weeks and at the end of the experiment (10 weeks). The blood and serum were processed in keeping with the standard procedures for the determination of each of the given parameters. Whole blood samples were collected from the lateral saphenous vein for hematological and biochemical analyses in a quiet, well-lit area to minimize stress. The rabbits were restrained in a towel, with the head covered, and held in lateral recumbency. The legs were extended and the fur that overlies the vein was delicately clipped. The skin was kept taut to immobilize the vein for blood collection. A 21-gauge needle fastened to a 5-mL syringe was used to collect the blood sample. To avoid hepatoma formation, gentle suction was followed by firm pressure after sampling.

Analysis of hematological parameters

Red blood cell (RBC) count, haemoglobin (HGB) concentration, haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), white blood cell (WBC) count and platelet (PLT) count, packed cell volume (PCV), red cell distribution width (RDW), and mean platelet volume (MPV) in rabbits fed experimental diets were determined by fully automated haematology analyser Horiba ABX (Horiba Medical) using commercially available diagnostic kits (Horiba ABX Diagnostics). Moreover, leucocytes counts were determined with particular counts of lymphocytes, monocytes, and heterophils.

For biochemical assays, blood serum was separated by centrifugation at 3000×g for 10 min. The separated serum was stored at − 20 °C for analysis.

Biochemical analysis

Serum concentration of triglycerides (TG), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) were measured by enzyme-assay using commercial kits using ABX Pentra 400 (Horiba Medical). The fraction of plasma low-density cholesterol (LDL-C) was performed using LDL-C Direct CP kits from Horiba. VLDL-C in rabbits was calculated based on the formula VLDL Cholesterol = Total cholesterol - (HDL-C + LDL-C). For better expression of the relationship between triglycerides and HDL-C, atherogenic index of plasma (AIP) factor based on the ratio of the values of triglycerides to high-density lipoprotein (HDL-C) levels was calculated according to the following formula (AIP = Log [TGs]/ [HDL-C]) where both of them are measured in the plasma. AIP is used as a logarithmically transformed value because it produced better correlations and normal probability plots [19, 20]. Moreover, other atherogenic factors (AF) was calculated as the difference between non-HDL-C and HDL-C, LDL-C and HDL-C [21,22,23,24,25]. Total antioxidative status (TAS) and superoxide dismutase activities (SOD) were determined spectrophotometrically in serum using a kit from the Randox (Randox Laboratories Ltd., UK).

Statistical analysis

Continuous variables are expressed as the mean ± standard deviation (SD). D’Agostino-Pearson normality tests were used to test for a normally distributed population [26]. Individual laboratory parameters were compared between groups by one-way analysis of variance (ANOVA) for feeding effects followed by the Bonferroni multiple-comparison test. Post hoc comparisons were made when appropriate. Multiple comparisons were performed only when ANOVA P-values were significant. The P-value was calculated under the null hypothesis that the samples were drawn from the same distribution. Statistical significance for ANOVA was accepted at a P-value less than 0.05. Diet effects and time effects (6 vs 10 weeks of diet), as well as diet × time, interactions were considered significant at P < 0.05. To assess the influence of dietary flaxseed, time of blood sampling and lipid contents of serum. Moreover, the heterophil-to-lymphocyte ratio (HLR), the platelet-to-lymphocyte ratio (PLR), and MPV to lymphocyte ratio (MPVLR) were calculated. All analyses were performed with Statistica 13.1 (Dell Inc., 2016) and R software (R Foundation Statistical Computing, Free Software Foundation, Inc.).

Results

Fatty acid analyses of flaxseed

The analysis of the fatty acid composition of the flaxseed from Linola and transgenic W86 demonstrated significant accumulation (P > 0.05) of ALA (~ 30 times more compared to maternal Linola, Table 1 and Additional file 1: Table S3). Furthermore, the W86 seed had significantly decreased percentages of LA (~ 37.7%).

Table 1 Fatty acid composition (percentage of fatty acids) of the flaxseeda
Full size table

In general terms, the flaxseed from Linola and W86 varieties had no significant (P > 0.05) different percentage of saturated and unsaturated fatty acids as well as PUFA and MUFA (Table 1). However, the n3/n6 fatty acid ratio is 0.588 in W86 flaxseed and is higher than in original Linola cultivar flaxseed (0.022).

Effect of flaxseed on growth performance

The effects of dietary supplementations of flaxseed on growth performance and feed intake are summarized in Additional file 1: Table S4. There was no significant (P > 0.05) difference in final body weight of rabbits between all groups at the end of study (10 weeks). However, after 6 weeks of the diet, lower body weight was observed in CTRL and W86 groups (P < 0.05). Moreover, significant (P < 0.05) lower feed intake was reported in groups (LIN and W86) fed high cholesterol diet supplemented with flaxseed compared to both CTRL and CHOL groups. No significant changes in feed intake were observed after 10 weeks. So, on the other hand, after 10 weeks of breeding, the feed intake in the experimental groups was lower than the intake in 6 weeks: lower by 11.96% for the CTRL group and 11.97% for W86 group (P < 0.05). Significantly greater (P < 0.05) decline was observed in the group fed with cholesterol (16.13%) and in group LIN (14.69%).

Haematological parameters

Cholesterol enrichment of red cell membranes associated with haemolytic anaemia occurs in rodent species fed diets enriched with cholesterol. Similar observations have been made in rabbits (5, 6). The results of the hematological analysis obtained after feeding rabbits a diet with the addition of two flaxseed varieties (Linola or its transgenic derivative W86) are expressed in Tables 2 and 3.

Table 2 Effects of atherogenic diet supplemented with flaxseed on hematological parameters of rabbits*
Full size table
Table 3 Effects of atherogenic diet supplemented with flaxseed on WBC parameters of rabbits*
Full size table

It followed from the present study that RBC, HGB, and PCV significantly (P < 0.05) decreased in groups fed high cholesterol diet with or without flaxseed (Table 2). The red cell indices (MCV, MCH, MCHC, and RDW) that are useful for elucidating anemias did not differ significantly (P > 0.05) between all groups (Table 2) [27]. Moreover, these values were within the normal range according to respected values [28, 29]. It is already known that platelets express and secrete inflammatory mediators (chemokines, sp-selectin, interleukin-1β, thromboxane, cytokines) and that elevated platelet counts were related to poor cardiovascular clinical outcomes [30,31,32,33]. The differences between groups and sequential changes in the platelet count and the mean platelet volume are summarized in Table 2. The 6 weeks platelet counts were similar in CHOL and LIN groups. However, in group W86 the counts were higher (P < 0.05) and were lower in CTRL group (P < 0.05) than in the other groups. The counts statistically increase (P < 0.05) in groups CTRL, and CHOL and LIN at 10 weeks as compared to 6 weeks. Surprisingly, the biggest change value was observed in group LIN (P < 0.001). The basal values for MPV were similar in all the groups except in CTRL groups where was the significantly highest (P < 0.05). The values at the end of 10 weeks period were similar in all the groups. We also did not note sequential, time-related changes in MPV values.

Rabbit leucocytic values are reported in Table 3. The normal WBC count in rabbits varies from 7.5 to 13.5 × 109 L− 1 [29]. After 6 and 10 weeks of feeding, our results show a significant increase (P < 0.05) in WBC counts in LIN, W86 and CHOL groups compared to the CTRL group and slightly exceeded the normal value in group W86. Although, in contrast to the midterm result after 10 weeks, analyses showed a higher significant WBC increase in the W86 group. The sequential changes in WBC counts of the four groups are summarized in Table 3. At the end of 10 weeks, the values remained unaltered in all the groups except in group W86 where it increased as compared to the initial values (6 weeks).

The changes in the counts of lymphocytes, monocytes, and heterophils in the blood of the four experimental groups are summarized in Table 3. The total lymphocyte counts of all groups in both periods (6 and 10 weeks) differed markedly compared to CTRL group among treatments (P < 0.05) with a maximum value in group W86. At the end of 10 weeks, the values remained unchanged in groups CTRL, CHOL, and LIN but increased significantly (P < 0.05) in group W86 as compared to the 6 weeks values. On the other hand, the total monocytes count showed a non-significant (P > 0.05) level among all groups after 6 weeks, but at the end of experiment slightly but significant (P < 0.05) increase was observed in all groups compared to CTRL group. At the end of experimental periods, the values remained unaltered in all the groups as compared to first blood sampling. This study demonstrated that heterophils counts after 6 and 10 weeks were significantly (P < 0.05) higher in all groups compared to CTRL. Moreover, there were no differences between LIN, W86 and CHOL groups in both periods. It has also been demonstrated that heterophil counts significantly changes over time in all groups except in CTRL group.

Thrombocytosis and inflammation are vital elements in the pathogenesis of atherosclerosis. The platelet-to-lymphocyte ratio (PLR) is a novel biomarker that combines these parameters and has been shown to be associated with CVD. Moreover, previous research had also revealed a significant association between coronary heart risk and PLR and neutrophil-lymphocyte ratio NLR (HLR ratio for rabbit) [34, 35]. Rabbit has a heterophil instead of a neutrophil and rabbits heterophil functions like the neutrophil of other species and is only histochemically distinct [36].

In the current study, after 6 weeks, the HLR values was 0.5 ± 0.17 in the CTRL group, 0.49 ± 0.14 in the LIN group, 0.38 ± 0.12 in the W86 group, and 0.51 ± 0.42 in CHOL group (Fig. 1a). There was no statistically significant difference between the two groups (CTRL and LIN) in respect of the HLR values after both 6 (see above) and 10 weeks (0.49 ± 0.14 and 0.5 ± 0.14 respectively). However, a significant reduction of HLR occurred in a group of rabbits fed the atherogenic diet supplemented with W86 flaxseed (0.38 ± 0.12 and 0.4 ± 0.14) (Fig. 1a). The CHOL group showed statistically significantly (P < 0.05) higher HLR values (0.68 ± 0.44) compared to all groups after the 10 weeks period. In addition, this recent study (Fig. 1a) indicates a significant increase (P < 0.05) of HLR ratio in CHOL group over time.

Fig. 1
figure 1

Predictors of atherosclerosis and acute coronary syndrome. Comparison of HLR (a) PLR (b) and MPVLR ratio (c) between groups. Error bars represent standard deviations. Results are expressed as the means ± SD; statistically different values are marked with lower case letters (6 weeks) or capital letters (10 weeks) when a significant interaction was observed. Significant changes in the same group between 6 and 10 weeks (p < 0.05) are marked with an asterisk

Full size image

In a next step, a PLR value in all groups was calculated. The changes at both the 6 and 10 weeks in the PLR ratio in the four experimental groups are shown in Fig. 1b. The PLR values at 6 weeks in groups CTRL, LIN, W86, and CHOL were respectively 68.72 ± 29.96, 64.43 ± 19.28, 62.48 ± 26.57, and 54.20 ± 32.89. There was no difference in the PLR ration between the groups at the end of 6 weeks. The PLR values changed in groups CTRL, LIN, and CHOL but decreased in group W86 with respect to 6 weeks and were respectively 90.88 ± 39.27, 105.25 ± 26.47, 49.60 ± 21.94, and 71.20 ± 54.75. In second sampling periods, the PLR ratio in group W86 was significantly lower than in other groups (Fig. 1b). Moreover, only in this group, we observed a significant decrease in time (P < 0.05). In contrast, PLR ratio significantly increases (P < 0.05) in groups CTRL and LIN. We did not observe significant differences in PLR between CHOL and others group in the 10th week due to high standard deviation value in CHOL group.

The MPVLR data was presented in Fig. 1c. The most important observation is that in group W86 MPVRL significantly (P < 0.05) decreased over time during the study (from 0.61 ± 0.09 to 0.50 ± 0.07). In the other groups, no significant changes were noted between 6 and 10 weeks. Moreover, lowest MPVRL was also shown in group W86 at the 10th week of the experiment.

Biochemical parameters

The results of the biochemical blood analysis are shown in Tables 4 and 5. The concentrations of serum TC were changed in groups LIN, W86, and CHOL during the 6 and 10 weeks feeding period compared to CTRL group and was statistically significant (P < 0.05). Similar results were obtained for LDL-C and TG concentrations. Furthermore, the results show that the rabbits from groups LIN, W86 and CHOL were hypercholesterolemic. The inclusion of W86 variety of flaxseed into a diet of rabbits had statistically significant (P < 0.05) effects on the serum lipid compared to groups LIN and CHOL. Generally, we have observed that the TC and LDL-C concentration was significantly lower (P < 0.05) in rabbits supplemented with flaxseed from W86 variety compared to rabbits from LIN and CHOL groups. Similar results were obtained in the TG concentration of the hypercholesterolemic rabbits. Also, in this case, TG concentration was significantly lower (P < 0.05) compared to LIN and CHOL groups. Moreover, after 6 weeks of the experiment, the TG concentration was similar to TG concentration in CTRL group. There was no significant difference between the high cholesterol-fed groups in terms of HDL-C concentration. Moreover, these results demonstrate time stable (Table 4) levels of HDL-C in all groups in contrast to CTRL. Comparing of average serum lipids contents in rabbits supplemented with flaxseed from both varieties (maternal Linola and its W86 derivative) we have shown that W86 flaxseed possessed higher antiatherogenic potential.

Table 4 Effect of high-fat diet and flaxseed on lipid profile of controls and experimental rabbit groups*
Full size table
Table 5 Effect of high-fat diet and flaxseed on TAS and SOD values in the studied groups*
Full size table

Importantly observation was that in groups W86 and LIN significant decrease in VLDL-C contents were demonstrated after 10 days of feeding in contrast to the CHOL group (Table. 1). However, it was shown that better effects were observed in the W86 group (P < 0.05), since in group LIN this content was still higher than in group CHOL.

The effects of dietary Linola and W86 derivative flaxseed in a rabbit model, summarizing the atherogenic lipid ratios are presented in Fig. 2. Based on the data presented in Table 4, mean atherogenic lipid ratios: non-HDL-C: HDL-C (Fig. 2a) and LDL-C: HDL-C (Fig. 2b) were calculated. Furthermore, AIP index (Fig. 2c) and non-HDL-C content were also calculated (Table 4) [21,22,23, 25]. The non-HDL-C cholesterol is the sum of all the lipoproteins which contribute towards the development of atherosclerosis (narrowing of the arteries) and is thought to be a better predictor of cardiovascular disease (CVD) than using LDL-C alone (Table 4). In the present study, non-HDL-C levels remained unchanged throughout a period of observation in groups LIN and CHOL but slightly decreased (P > 0.061) at 10 weeks in group W86 as compared to 6 weeks results. Moreover, at the end of experiments (10 weeks) rabbits fed diet supplemented with W86 flaxseed shown significantly lower “non-HDL-C” level comparing to rabbits from CHOL and LIN groups. W86 treatment affected the derived non-HDL-C/HDL-C (Fig. 2a) and LDL-C/HDL-C ratios (Fig. 2b), and the AIP index (Fig. 2c). The animals of the W86 group showed significantly lower ratios of non-HDL-C/HDL-C, LDL-C/HDL-C, and AIP index than the rabbits in the other groups exclude CTRL group.

Fig. 2
figure 2

Effects of flaxseed on atherogenic indexes in rabbits fed hypercholesterolemic diet. a non-HDL-C/HDL-C, b LDL-C/HDL-C ratios and c AIP index of rabbits fed control diet (CTRL), high cholesterol diet (CHOL) and high cholesterol diet supplemented with flaxseed of Linola (LIN) or Linola W86 derivative (W86). Results are expressed as the means ± SD; statistically different values are marked with lower case letters (6 weeks) or capital letters when a significant interaction in 10 weeks was observed. Significant changes in the same group between 6 and 10 weeks (p < 0.05) are marked with an asterisk

Full size image

Linola flaxseed (group LIN) did not positively affect the AIP index nor LDL-C/HDL-C or non-HDL-C/HDL-C ratios. The non-HDL-C/HDL-C ratio was significantly higher (P < 0.05) than in CHOL group. Furthermore, LDL-C/HDL-C ratio and AIP index were similar in group LIN and CHOL.

The effects of high cholesterol diet, with and without dietary flaxseed, on SOD and TAS levels, are summarized in Table 5.

To evaluate the antioxidant effect of flaxseed on vascular in our experiment, we detected the serum levels of SOD and TAS. The results of the analysis were listed in Table 5. We can draw from the Table 5 that, compared to the CTRL group, serum SOD levels of rabbits in the others groups dropped greatly (P < 0.05), after high cholesterol diet in 6 and 10 weeks. The levels of SOD decrease (P < 0.05) between 6 and 10 weeks 93.80, 76.64 and 119.57 in groups, LIN, W86, and CHOL, respectively. However, decreases in the W86 group were significantly smaller (P < 0.05) than those in the LIN and CHOL groups. There were statistically significant differences (P < 0.05) in TAS between groups CTRL, LIN, W86 and CHOL after 10 weeks. As was mentioned above, in groups LIN and CHOL, rabbits had highest decreased SOD activities and TAS. It should be stressed that those were rabbits having the highest TC and LDL-C concentrations. In the same groups, higher LDL-C/HDL-C ratios and AIP index was observed.

Discussion

Naturally derived dietary supplements capable of modifying dyslipidemias are becoming more popular and attractive to patients. Among them are Linum usitatissimum L., the richest known source of PUFA, and lignans [6]. Most commonly used forms include flaxseed, flaxseed flour and flaxseed oil [37,38,39]. Moreover, nutraceuticals are an interesting option for patients with dyslipidemia owing to their safety, tolerability, and ability to lower plasma lipid levels and play a peculiar role in ameliorating human dyslipidemia [5, 40]. These roles of nutraceuticals were detailed reviewed by Scicchitano, et al. [5]. In their review, the authors focused on the mechanism of action of nutraceuticals and functional food ingredients on lipids and their role in the management of lipid disorders.

The aim of this study was to assess the impact of W86 flaxseed with increased phenylpropanoid compounds and hydrolysable tannin on hematological parameters and atherogenic indexes in a hypercholesterolemic diet based on the results in alterations in the lipid profile. Moreover, we investigated the effect of short-term use of flaxseed, with special emphasis on variety W86, in rabbits on the hemopoietic and lymphopoietic system.

Our results show that exposure of rabbits to W86 flaxseed during the full fattening period did not have a major impact on the body weight and feed intake. However, the feed intake in the experimental groups was lower at the end of this period than in 6 weeks and significantly greater (P < 0.05) decline was observed in the LIN group than in W86 group during the experiment.

In spite of the well-known variability of hematological parameters in rabbits with regard to breed-related and individual differences, the measured values of RBC, HGB, and PCV count in this research occur within the range of reference physiologic values for rabbits [29]. Although, the values of the RBC in blood in three groups (CHOL, LIN, and W86), were near the bottom level of the range stipulated for adult New Zealand white rabbits (4–7.2 × 1012 L− 1), in our opinion the RBC, HGB and PCV values just like MCV, MCH, MCHC, and RDW were physiological for the age of the tested rabbits [28, 29]. Moreover, demonstrated results suggest that use of W86 flaxseed does not have deleterious effects on the hemopoietic system.

Studies on HLR, PLR, and MPV have grown recently following the discovery of their immense values in prediction and prognosis of many medical conditions and are potent markers of inflammation which underlies the basic pathologies of various diseases [41,42,43]. Furthermore, the chronic inflammatory response is a critical element in the pathogenesis of atherosclerosis and is associated with the production of lymphocytes and PLT. Elevated activated platelets count promotes atherothrombosis, atherosclerosis formation, progression, and destabilization of atherosclerotic plaques, and are associated with an incidence of CAD [44, 45]. The present results demonstrated that there was an increase in platelet counts in both CHOL and LIN groups. However, PLT values in rabbits supplemented with W86 flaxseed at week 10 were the same as in the CTRL group.

Cardiovascular events are primarily associated with a high circulating platelet count and low blood lymphocytes. Moreover, the PLR has come into use recently as an indicator of the balance between inflammation and thrombosis and act as an effective biomarker to predict CVD risk [44]. Furthermore, PLR gives an idea about both the aggregation and inflammation pathways and it may be more valuable than either platelet or lymphocyte count alone in the prediction of coronary atherosclerotic burden [46]. High PLR values are associated with cardiovascular diseases and adverse outcomes [47]. It has been reported that NLR (analogue of HLR) is a marker for progression of atherosclerosis in coronary artery disease and a marker for possible cardiac events and mortality in patients with stable coronary artery disease [34, 48]. The present results demonstrated that W86 flaxseed significantly decreased PLR and HRL ratios in rabbits fed high cholesterol diet. Moreover, W86 flaxseed significantly decreased MPVLR in contrast to parental Linola flaxseed (group LIN). Several studies reviewed by Nording, et al. [32] support the roles of platelets in chronic low-grade inflammation driving atherosclerosis. In our study, we found that W86 flaxseed positively influenced on the PLT count. The PLT of the high cholesterol-W86 fed groups was statistically significantly lower than that of the CHOL, and LIN groups and similar to CTRL. This result suggests that W86 flaxseed with increased phenylpropanoid compounds, hydrolysable tannin, and the well balanced ω-6/ω-3 ratio can prevent thrombocytosis and eventually atherosclerotic lesions.

The rabbit fed with typical laboratory chow diets contain typical plasma cholesterol concentrations in the range of ~ 0.78–0.91 mmol L− 1 as we showed in CTRL group [29, 49]. The rabbit rapidly develops severe hypercholesterolemia leading to premature atherosclerosis in response to dietary manipulation. Diets containing high cholesterol amounts (0.3–0.5%) have demonstrated that the hypercholesterolemic rabbit can develop complex, advanced lesions that more closely resemble those found in humans [50, 51]. In this study, a high-cholesterol diet resulted in hypercholesterolemia in rabbits, and blood TG and TC levels were increased compared to that measured in CTRL counterparts group.

The increased use of ALA is a powerful example of one such nutritional strategy that may produce significant cardiovascular benefits. Based on the results of clinical trials, epidemiological investigations and experimental studies, ingestion of ALA has been suggested to have a positive impact on CVD. Increased linoleic intake has been shown to promote platelet aggregation and oxidation of LDL. Renaud, et al. [52] demonstrated that α-linolenic acid has antithrombotic properties and may also be antiarrhythmic. Moreover, α-linolenic acid is a precursor of other omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which may have independent beneficial effects [53]. Harper, et al. [54] showed that patients which received linseed capsules demonstrated a 25% increase in the plasma values of docosapentaenoic acid (DPA), a cardioprotective fatty acid in the linseed group while the olive oil group showed no changes.

The HDL-C is recently gaining sample scientific attention due to its antiatherogenic properties providing cardioprotection. The relationship between HDL-C and cardiovascular diseases is primarily due to cholesterol efflux facilitated by apolipoprotein A1 during the process called the reverse cholesterol transport and HDL-C acceptors or by diffusion leads to HDL-C mobilization from cell membrane to hepatic storage. In addition to this, HDL-C exerts antithrombotic activity by preventing platelet aggregation [55]. Furthermore, HDL-C prevents oxidative modification of LDL and blocks the pro-inflammatory effects of oxidized LDL [56]. However, Prasad, et al. [57] showed that HDL-C can also have proinflammatory effects. In the research of Bierenbaum, et al. [58] hyperglycaemic patients who received linseed together with vitamin E daily for 3 months exhibited a significant reduction in serum TC, LDL-C and serum lipid oxidation products while HDL-C did not change at all. In this trial, statistically insignificant changes (P = 0.09) between group CTRL, LIN, and W86 were observed in HDL-C levels in rabbits at week 10 in contrast to group CHOL. However, this statistically significant increase should be rather considered together with generally high TC and lipoprotein content in rabbit fed cholesterol without flaxseed.

Peng, et al. [59] stated in their review, that a large number of studies have shown that hypertriglyceridemia contributes to the development and progression of atherosclerosis. However, the proatherogenic mechanism of hypertriglyceridemia seems rather complicated and needs to be further investigated. Based on current knowledge and the evidence of clinical studies, controlling and lowering plasma TG levels is one of the important measures to further reduce the residual risk of CVD events in atherosclerotic CAD patients. Stuglin and Prasad [60] suggested that the linseed increased the TG level while the others demonstrated the reduction in TG concentration induced by the linseed [61]. In our study, TG concentration was lowered through both linseed supplementation in contrast to CHOL group. However, herein we show that W86 flaxseed showed more beneficial effect than flaxseed from the parental variety. What is more important is that W86 flaxseed in contrast to parental variety reduced not only TG but also TC level in hypercholesterolemic rabbits (P = 0.034). This result is opposed to the previous observation of Dupasquier, et al. [62]. These authors showed that flaxseed in the diet reduced serum TG but had no effect on serum TC in rabbits. Moreover, Prasad [63] reported an increase in serum TC and no change in serum TG in rabbits on a flaxseed diet as we have shown for Linola flaxseed (group LIN).

The non-HDL-C incorporates the harmful elements of the lipoprotein profile to include TG rich remnant particles from VLDL and IDL, as well as LDL-cholesterol. It is also better for monitoring response to treatments such as lifestyle changes and medication. The non-HDL-C has been recommended as the target for lipid modification in guidelines by the National Institute for Health and Care Excellence. Moreover, the non-HDL-C includes all ApoB containing lipoproteins and for this reason, the non-HDL-C/HDL-C ratio provides cardiovascular risk stratification similar to the ApoB/ApoA1 ratio in diabetics as a comparison with reference lipid marker [64]. Herein, we provided evidence for the non-HDL-C, VLDL-C and LDL-C lowering properties of W86 flaxseed in contrast to Linola seeds.

Atherogenic indexes are considered as a better indicator of coronary heart disease risk than individual lipoprotein concentration. The results of the present study showed that W86 flaxseed also caused a significant reduction in all calculated atherogenic indexes. Furthermore, this beneficial effect is more valuable than was observed for Linola.

The high-fat diet also causes oxidative stress, thus, increases oxidation of LDL which plays a key role in the genesis of atherosclerosis but antioxidants such as flavonoids are known to effectively prevent this kind of damage [65]. The presence of the strong antioxidant in the flaxseed such as anthocyanins, flavones, and proanthocyanins may also offer additional benefit against oxidative stress caused by high cholesterol. Flaxseed from W86 cultivar contains more lignans and tannins than its parental Linola (Additional file 1: Table S1). The most remarkable lignan is secoisolariciresinol diglucoside (SDG), a very potent antioxidant [66]. The beneficial effect of flax lignan complex was reviewed by Prasad [67]. Moreover, Gato, et al. [68] indicate that tannin is a useful food material for treating hypercholesterolemia while Si, et al. [69] reported antioxidant activity of tannins. In the present study, we used SOD radical scavenging properties to examine the antioxidant blood activity. Nevertheless, another recently developed method measuring the total antioxidant status (TAS) provides the evaluation efficiency of the biological interactions between individual antioxidant species such as antioxidant enzymes and low-molecular-weight antioxidants and also a measure of the capacity of biological systems to withstand oxidative attack [70]. Statistical analysis showed significant differences among study groups in the levels of TAS and SOD between 6 and 10 weeks and in all groups both parameters decreased after 10 weeks. No statistically significant differences were found in serum TAS values among groups after 6 weeks. In group LIN we demonstrated a drastic decrease of TAS at 10 weeks in contrast to a W86 group. The present findings are in agreement with previous observations showed that flaxseed oil had no effect on the activity of SOD or flaxseed oil increased the levels of lipid peroxidation and that this effect was associated with the reduction in SOD activity [71, 72]. The research data suggest that antioxidant activity of flaxseed seems to be due to the SDG present in these components [73]. The findings of the present investigation confirm those reports and expand previous observations by demonstrating that W86 flaxseed richer in phenylpropanoid compounds, flavonoids and hydrolysable tannin than Linola can better slow the progression of atherosclerosis by reducing oxidative stress. Additionally, the amount of ALA that is present in the diet is very small, and dietary supplementation is needed whenever increased oxidative stress in the body leads to clinically significant consumption of endogenous antioxidants.

Moreover, McCullough, et al. [74] demonstrated that ALA content of flaxseed is associated with an induction of adipose leptin expression encoded by the “obese” gene. Leptin protein levels were elevated in animals taking diet supplemented with 10% flaxseed. Changes in leptin expression were strongly and positively correlated with adipose ALA levels and inversely correlated with risk of atherosclerosis. W86 flaxseed contains ~ 30-fold excess of ALA than parental Linola and may be a good supplement to obesity prevention but this suggestion should be further investigated.

Limitations of the study

Our study has some limitations including the routine measurement of HDL-C, without HDL-C subclass assessment, we cannot discriminate between atheroprotective vs. dysfunctional, less atheroprotective or even atherogenic particles. Lack of other established inflammatory markers, such as C-reactive protein, and tumor necrosis factor-a, is another limitation of the study. The findings of the study should be generalized across CAD and atherosclerotic patients in clinical practice. Moreover, a molecular study needs to be performed to more accurately explain the beneficial effect of genetically modified flax W86. Another limitation of this study is that since the CTRL group was not administered any flaxseed supplementation.

Conclusions

The present study suggested that W86 flaxseed from genetically modified Linola affect lipid metabolism and lower atherogenic indexes in rabbits. Accurate documentation of the therapeutic effects of W86 flaxseed and its components that contribute uniquely to disease prevention health protection and as a deterrent to degenerative diseases will increase its potential for use as a functional food and food ingredient. Hence, we can conclude that W86 flaxseed provides a safe and relatively inexpensive alternative for reducing cholesterol and thereby the risk of CVD and be a good supplement in atherosclerosis and obesity prevention. Moreover, we believe that this result supports the hypothesis of about the use of nutraceuticals in primary cardiovascular prevention, protocols to reduce the overall burden of cardiovascular disease morbidity and mortality as was suggested by Scicchitano, et al. [5]. Nevertheless, further studies are needed to implement the actual findings associated with this hypothesis.

Abbreviations

AIP:

Atherogenic index of plasma

ALA:

α-linolenic acid

CAD:

Coronary artery disease

CVD:

Cardiovascular disease

HCT:

Hematocrit

HDL-C:

High density lipoprotein cholesterol

HGB:

Hemoglobin concentration

HLR:

Heterophil-to-lymphocyte ratio

LA:

Linoleic acid

LDL-C:

Low density lipoprotein cholesterol

MCH:

Mean corpuscular hemoglobin

MCHC:

Mean corpuscular hemoglobin concentration

MCV:

Mean corpuscular volume

MPV:

Mean platelet volume

MPVLR:

MPV to lymphocyte ratio

MUFA:

Monounsaturated fatty acids

PCV:

Packed cell volume

PLR:

Platelet-to-lymphocyte ratio

PLT:

Platelets

PUFA:

Polyunsaturated fatty acids

RBC:

Red blood cells

RDW:

Red cell distribution width

SD:

Standard deviation

SOD:

Superoxide dismutase

TAS:

Total antioxidative status

TC:

Total cholesterol

TG:

Triglyceride

WBC:

White blood cells

References

  1. Martinez-Fernandez L, Pons Z, Margalef M, Arola-Arnal A, Muguerza B. Regulation of vascular endothelial genes by dietary flavonoids: structure-expression relationship studies and the role of the transcription factor KLF-2. J Nutr Biochem. 2015;26(3):277–84.

    Article  CAS  PubMed  Google Scholar 

  2. Akboga MK, Canpolat U, Yayla C, Ozcan F, Ozeke O, Topaloglu S, Aras D. Association of Platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67(1):89–95.

    Article  CAS  PubMed  Google Scholar 

  3. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195–211.

  4. Keyamura Y, Nagano C, Kohashi M, Niimi M, Nozako M, Koyama T, Yasufuku R, Imaizumi A, Itabe H, Yoshikawa T. Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin. PLoS One. 2014;9(5):e96929.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32.

    Article  CAS  Google Scholar 

  6. Oomah BD. Flaxseed as a functional food source. J Sci Food Agric. 2001;81(9):889–94.

    Article  CAS  Google Scholar 

  7. Bradberry JC, Hilleman DE. Overview of Omega-3 fatty acid therapies. P T. 2013;38(11):681–91.

    PubMed  PubMed Central  Google Scholar 

  8. Simopoulos A. An increase in the Omega-6/Omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gómez Candela C, Bermejo López LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 2011;26:323–9.

    PubMed  Google Scholar 

  10. McDaniel J, Ickes E, Holloman C. Beneficial n-3 polyunsaturated fatty acid levels and n6:n3 ratios after 4-week EPA + DHA supplementation associated with reduced CRP: a pilot study in healthy young adults. Mod Res Inflamm. 2013;2(4):10.

    Article  Google Scholar 

  11. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid a and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167(2):237–42.

    Article  CAS  PubMed  Google Scholar 

  12. Zuk M, Prescha A, Stryczewska M, Szopa J. Engineering flax plants to increase their antioxidant capacity and improve oil composition and stability. J Agric Food Chem. 2012;60(19):5003–12.

    Article  CAS  PubMed  Google Scholar 

  13. Austria JA, Richard MN, Chahine MN, Edel AL, Malcolmson LJ, Dupasquier CMC, Pierce GN. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr. 2008;27(2):214–21.

    Article  PubMed  Google Scholar 

  14. Bosze Z, Houdebine LM. Application of rabbits in biomedical research: a review. World Rabbit Sci. 2006;14(1):01–14.

    Google Scholar 

  15. Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004;38(3):246–56.

    Article  CAS  PubMed  Google Scholar 

  16. Zuk M, Działo M, Richter D, Dymińska L, Matuła J, Kotecki A, Hanuza J, Szopa J. Chalcone synthase (CHS) gene suppression in flax leads to changes in wall synthesis and sensing genes, Cell Wall chemistry and stem morphology parameters. Front Plant Sci. 2016;7:894.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kroliczewska B, Mista D, Kroliczewski J, Zawadzki W, Kubaszewski R, Wincewicz E, Zuk M, Szopa J. A new genotype of flax (Linum usitatissimum L.) with decreased susceptibility to fat oxidation: consequences to hematological and biochemical profiles of blood indices. J Sci Food Agric. 2017;97(1):165–71.

    Article  CAS  PubMed  Google Scholar 

  18. Kroliczewska B, Mista D, Zawadzki W, Wypchlo A, Kroliczewski J. Effects of a skullcap root supplement on haematology, serum parameters and antioxidant enzymes in rabbits on a high-cholesterol diet. J Anim Physiol Anim Nutr. 2011;95(1):114–24.

    Article  CAS  Google Scholar 

  19. Dobiášová M, Frohlich J, Šedová M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52(3):566–71.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tan MH, Johns D, Glazer NB. Pioglitazone reduces Atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004;50(7):1184–8.

    Article  CAS  PubMed  Google Scholar 

  21. Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, et al. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease. Lipids Health Dis. 2015;14(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  22. da Luz PL, Favarato D, Junior JRF-N, Lemos P, Chagas ACP. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo, Brazil). 2008;63(4):427–32.

    Google Scholar 

  23. Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb. 2004;11(1):6–14.

    Article  CAS  PubMed  Google Scholar 

  24. Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, Masana L, Mangas A, Hernández-Mijares A, González-Santos P, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.

    PubMed  PubMed Central  Google Scholar 

  25. Eliasson B, Gudbjörnsdottir S, Zethelius B, Eeg-Olofsson K, Cederholm J. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. Eur J Prev Cardiol. 2013;21(11):1420–8.

    Article  PubMed  Google Scholar 

  26. D'Agostino RB, Belanger A, D'Agostino RB. A suggestion for using powerful and informative tests of normality. Am Stat. 1990;44(4):316–21.

    Google Scholar 

  27. Kale V, Aftab AR: Diagnostic evaluation of Anaemia. In: Anemia. Edited by Silverberg D: InTech; 2012: 75–92.

  28. Hewitt CD, Innes DJ, Savory J, Wills MR. Normal biochemical and hematological values in New Zealand white rabbits. Clin Chem. 1989;35(8):1777–9.

    CAS  PubMed  Google Scholar 

  29. Harkness JE, Turner PV, VandeWoude S, Wheler CL. Harkness and Wagner’s biology and medicine of rabbits and rodents. 5th ed. Ames, Chester: Wiley-Blackwell; American College of Laboratory Animal Medicine; 2010.

    Google Scholar 

  30. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84(2):613–7.

    Article  CAS  PubMed  Google Scholar 

  31. Wang X, Xie Z, Liu X, Huang X, Lin J, Huang D, Yu B, Hou J. Association of Platelet to lymphocyte ratio with non-culprit atherosclerotic plaque vulnerability in patients with acute coronary syndrome: an optical coherence tomography study. BMC Cardiovasc Disord. 2017;17(1):175.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Nording HM, Seizer P, Langer HF. Platelets in inflammation and Atherogenesis. Front Immunol. 2015;6:98.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ahmadsei M, Lievens D, Weber C, von Hundelshausen P, Gerdes N. Immune-mediated and lipid-mediated platelet function in atherosclerosis. Curr Opin Lipidol. 2015;26(5):438–48.

    Article  CAS  PubMed  Google Scholar 

  34. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  35. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, Eller P, Rief P, Hackl G, Pilger E, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8(7):e67688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Harkness JE, Turner PV, VandeWoude S, Wheler CL. Hematology, clinical chemistry, and urinalysis. In: biology and medicine of rabbits and rodents. 5th ed. Ames, IA: Wiley; 2013. p. 116–31.

  37. Aliani M, Ryland D, Pierce GN. Effect of flax addition on theflavor profile and acceptability of bagels. J Food Sci. 2012;71:62–70.

    Article  Google Scholar 

  38. Fitzpatrick K. Health benefits of flaxseed. Urbana: AOCS Press; 2011.

    Book  Google Scholar 

  39. Singh KK, Mridula D, Rehal J, Barnwal P. Flaxseed: a potential source of food, feed and fiber. Crit Rev Food Sci Nutr. 2011;51(3):210–22.

    Article  CAS  PubMed  Google Scholar 

  40. Sahebkar A, Serban MC, Gluba-Brzozka A, Mikhailidis DP, Cicero AF, Rysz J, Banach M. Lipid-modifying effects of nutraceuticals: an evidence-based approach. Nutrition. 2016;32(11–12):1179–92.

    Article  CAS  PubMed  Google Scholar 

  41. Alexander NI. Reference values of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in healthy adults in north Central Nigeria. J Blood Lymph. 2016;6(1):143.

    Google Scholar 

  42. Altunayoglu Cakmak V, Ozsu S, Gulsoy A, Akpinar R, Bulbul Y. The significance of the relative lymphocyte count as an independent predictor of cardiovascular disease in patients with obstructive sleep apnea syndrome. Med Princ Pract. 2016;25(5):455–60.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Budzianowski J, Pieszko K, Burchardt P, Rzezniczak J, Hiczkiewicz J. The role of hematological indices in patients with acute coronary syndrome. Dis Markers. 2017;2017:9.

    Article  Google Scholar 

  44. Zhou D, Wang G, Fan Y, Wan Z, Liu X. Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population. Exp Ther Med. 2017;13(2):731–8.

    Article  PubMed  Google Scholar 

  45. Suades R, Padro T, Vilahur G, Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost. 2012;108(6):1208–19.

    Article  PubMed  Google Scholar 

  46. Yüksel M, Yıldız A, Oylumlu M, Akyüz A, Aydın M, Kaya H, Acet H, Polat N, Bilik MZ, Alan S. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2016;15(8):640–7.

    Article  Google Scholar 

  47. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997;79(6):812–4.

    Article  CAS  PubMed  Google Scholar 

  48. Kalay N, Dogdu O, Koc F, Yarlioglues M, Ardic I, Akpek M, Cicek D, Oguzhan A, Ergin A, Kaya MG. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology. 2012;63(3):213–7.

    Article  PubMed  Google Scholar 

  49. Daley SJ, Herderick EE, Cornhill JF, Rogers KA. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 1: differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler Thromb. 1994;14:95–104.

    Article  CAS  PubMed  Google Scholar 

  50. Daley SJ, Klemp KF, Guyton JR, Rogers KA. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arterioscler Thromb. 1994;14:105–14.

    Article  CAS  PubMed  Google Scholar 

  51. Fan J, Kitajima S, Watanabe T, Xu J, Zhang J, Liu E, Chen YE. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2015;0:104–19.

    Article  Google Scholar 

  52. Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61(6 Suppl):1360s–7s.

    Article  CAS  PubMed  Google Scholar 

  53. Medicine Io. Nutrition and traumatic brain injury: improving acute and subacute health outcomes in military personnel. Washington: The National Academies Press; 2011.

    Google Scholar 

  54. Harper CR, Edwards MJ, DeFilippis AP, Jacobson TA. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr. 2006;136(1):83–7.

    Article  CAS  PubMed  Google Scholar 

  55. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006;98(11):1352–64.

    Article  CAS  PubMed  Google Scholar 

  56. Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004;109(23 suppl 1):20–6.

    Google Scholar 

  57. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation. 2002;106(2):184–90.

    Article  PubMed  Google Scholar 

  58. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr. 1993;12(5):501–4.

    Article  CAS  PubMed  Google Scholar 

  59. Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017;16(1):233.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Stuglin C, Prasad K. Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans. J Cardiovasc Pharmacol Ther. 2005;10(1):23–7.

    Article  CAS  PubMed  Google Scholar 

  61. Bhathena SJ, Ali AA, Mohamed AI, Hansen CT, Velasquez MT. Differential effects of dietary flaxseed protein and soy protein on plasma triglyceride and uric acid levels in animal models. J Nutr Biochem. 2002;13(11):684–9.

    Article  CAS  PubMed  Google Scholar 

  62. Dupasquier CM, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JS, Moghadasian MM, et al. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol. 2006;291(6):H2987–96.

    Article  CAS  PubMed  Google Scholar 

  63. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132(1):69–76.

    Article  CAS  PubMed  Google Scholar 

  64. Chowdhury S, Chowdhury J, Goswami S. The importance of non high density lipoprotein cholesterol in Dyslipidaemia management. J Diabetes Metab. 2015;623(11):1–5.

    Google Scholar 

  65. Kinosian B, Glick H, Preiss L, Puder KL. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med. 1995;43(5):443–50.

    CAS  PubMed  Google Scholar 

  66. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flax-seed. Mol Cell Biochem. 1997;168(1–2):117–23.

    Article  CAS  PubMed  Google Scholar 

  67. Prasad K. Flaxseed and cardiovascular health. J Cardiovasc Pharmacol. 2009;54(5):369–77.

    Article  CAS  PubMed  Google Scholar 

  68. Gato N, Kadowaki A, Hashimoto N, Yokoyama S, Matsumoto K. Persimmon fruit tannin-rich Fiber reduces cholesterol levels in humans. Ann Nutr Metab. 2013;62(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  69. Si HS, Kyoung HK, Byong TJ, Sun HC, Jae HP, Dong HK, Hyuk JK, Sang HM. Antibacterial and antioxidant activities of tannins extracted from agricultural by-products. J Med Plants Res. 2012;6(15):3072–9.

    Google Scholar 

  70. Zawadzka-Bartczak E. Activities of red blood cell anti-oxidative enzymes (SOD, GPx) and total anti-oxidative capacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots. Med Sci Monit. 2005;11(9):Cr440–4.

    CAS  PubMed  Google Scholar 

  71. Kaasgaard SG, Holmer G, Hoy CE, Behrens WA, Beare-Rogers JL. Effects of dietary linseed oil and marine oil on lipid peroxidation in monkey liver in vivo and in vitro. Lipids. 1992;27(10):740–5.

    Article  CAS  PubMed  Google Scholar 

  72. L'Abbe MR, Trick KD, Beare-Rogers JL. Dietary (n-3) fatty acids affect rat heart, liver and aorta protective enzyme activities and lipid peroxidation. J Nutr. 1991;121(9):1331–40.

    Article  PubMed  Google Scholar 

  73. Prasad K. Flaxseed and its components in coronary artery and peripheral vascular disease. In: Maulik N, editor. Cardiovascular diseases: nutritional and therapeutic interventions. Boca Raton: CRC Press; 2013.

    Google Scholar 

  74. McCullough RS, Edel AL, Bassett CM, Lavallee RK, Dibrov E, Blackwood DP, Ander BP, Pierce GN. The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression. Lipids. 2011;46(11):1043–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Prescott MJ, Lidster K. Improving quality of science through better animal welfare: the NC3Rs strategy. Lab Anim (NY). 2017;46(4):152–6.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Publication costs were supported by Wrocław Center for Biotechnology programme "National Scientific Leadership Center (KNOW) for the 2014–2018" awarded to BK. The funders had no role in study design data collection and analysis decision to publish or in the preparation of the manuscript.

Availability of data and materials

All data generated or analysed during this study are included in this published article and its supplementary information files.

Author information

Author notes

    Authors and Affiliations

    1. Department of Animal Physiology and Biostructure, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375, Wroclaw, Poland

      Bożena Króliczewska, Dorota Miśta, Ewa Pecka-Kiełb & Wojciech Zawadzki

    2. Sanitary and Epidemiological Inspection, Mickiewicza 24, 59-220, Legnica, Poland

      Angelika Ziarnik

    3. Department of Genetic Biochemistry, Faculty of Biotechnology, University of Wroclaw, Przybyszewskiego 63/77, 51-148, Wroclaw, Poland

      Magdalena Żuk

    4. Department of Genetics, Plant Breeding and Seed Production, Faculty of Life Sciences and Technology, Wroclaw University of Environmental and Life Sciences, Norwida 31, 50-375, Wroclaw, Poland

      Jan Szopa

    5. Department of Biology and Pharmaceutical Botany, Faculty of Pharmacy with Subfaculty of Laboratory Medicine, Medical University of Gdansk, Hallera 107, 80-416, Gdansk, Poland

      Jarosław Króliczewski

    Authors
    1. Bożena Króliczewska
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Dorota Miśta
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Angelika Ziarnik
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Magdalena Żuk
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Jan Szopa
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ewa Pecka-Kiełb
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Wojciech Zawadzki
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Jarosław Króliczewski
      View author publications

      You can also search for this author in PubMed Google Scholar

    Contributions

    This study was conceived and designed by BK and DM. Experiments on animals were performed by AZ, BK, DM, and EPK. JS and MŻ conceived of the plant study and carried out the biochemical analysis of plants. The data were analysed by BK, JK, DM and AZ. Reagents/materials/analysis tools were contributed by BK, DM, WZ, MŻ and JS. The paper was written by BK and JK and all authors read and approved the final manuscript.

    Corresponding author

    Correspondence to Jarosław Króliczewski.

    Ethics declarations

    Authors’ information

    Not applicable.

    Ethics approval

    This study was carried out in strict accordance with the recommendations of institutional and national guidelines for the care and use of laboratory animals and in accordance with the principals of Replacement. Reduction and Refinement (3Rs) [75]. The protocol was approved by the Second Wrocław Local Ethics Committee for Animal Experimentation of the Wroclaw University of Environmental and Life Sciences, Poland (Permit Number 60/2013 of 15 July 2013).

    Consent for publication

    Not applicable.

    Competing interests

    The authors have read the journal’s policy and have the following conflicts: Angelika Ziarnik has paid employment at Sanitary and Epidemiological Inspection, Legnica, Poland. The other authors have no competing interests. This does not alter the authors’ adherence to all the BioMed Central policies on sharing data and materials.

    Publisher’s Note

    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    Additional file

    Additional file 1:

    Table S1. Biochemical composition of W86 seeds used in this study (mg g− 1) in dry weight. The results are reported as a mean ± SD. (n = 4). Table S2. The chemical analyses of basal diet. Table S3. Fatty acid composition of the flaxseed used in this study (g/kg FW*). Table S4. Average values of body weight and feed intake during the experimental period. The results are reported as a mean ± SD, (n = 7). (DOCX 38 kb)

    Rights and permissions

    Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Króliczewska, B., Miśta, D., Ziarnik, A. et al. The effects of seed from Linum usitatissimum cultivar with increased phenylpropanoid compounds and hydrolysable tannin in a high cholesterol-fed rabbit. Lipids Health Dis 17, 76 (2018). https://doi.org/10.1186/s12944-018-0726-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1186/s12944-018-0726-4

    Keywords

    • Flaxseed
    • Cholesterol
    • Diet
    • Lipid profile
    • GMO

    Lipids in Health and Disease

    ISSN: 1476-511X